Relay Therapeutics Inc’s filing revealed that its insider Rahmer Peter unloaded Company’s shares for reported $9823.0 on Oct 28 ’24. In the deal valued at $6.06 per share,1,621 shares were sold. As a result of this transaction, Rahmer Peter now holds 390,063 shares worth roughly $2.32 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Catinazzo Thomas sold 6,802 shares, generating $41,220 in total proceeds. Upon selling the shares at $6.06, the Chief Financial Officer now owns 306,391 shares.
Before that, Catinazzo Thomas sold 2,300 shares. Relay Therapeutics Inc shares valued at $13,685 were divested by the Chief Financial Officer at a price of $5.95 per share. As a result of the transaction, Catinazzo Thomas now holds 304,091 shares, worth roughly $1.81 million.
Jefferies upgraded its Relay Therapeutics Inc [RLAY] rating to a Buy from a a Hold in a research note published on September 10, 2024; the price target was increased to $16 from $10.60. Oppenheimer also remained covering RLAY and has decreased its forecast on September 10, 2024 with a “Perform” recommendation from previously “an Outperform” rating. Barclays revised its rating on May 10, 2024. It rated RLAY as “an Overweight” which previously was an “an Equal weight”.
Price Performance Review of RLAY
On Tuesday, Relay Therapeutics Inc [NASDAQ:RLAY] saw its stock fall -3.57% to $5.94. Over the last five days, the stock has lost -0.17%. Relay Therapeutics Inc shares have fallen nearly -46.05% since the year began. Nevertheless, the stocks have fallen -22.45% over the past one year. While a 52-week high of $12.14 was reached on 01/08/24, a 52-week low of $5.60 was recorded on 10/31/24. SMA at 50 days reached $6.76, while 200 days put it at $7.47.
Levels Of Support And Resistance For RLAY Stock
The 24-hour chart illustrates a support level at 5.84, which if violated will result in even more drops to 5.73. On the upside, there is a resistance level at 6.11. A further resistance level may holdings at 6.28. The Relative Strength Index (RSI) on the 14-day chart is 41.54, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.11, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 62.22%. Stochastics %K at 48.80% indicates the stock is a holding.
How much short interest is there in Relay Therapeutics Inc?
A steep rise in short interest was recorded in Relay Therapeutics Inc stocks on 2024-10-31, dropping by -0.33 million shares to a total of 12.04 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 12.37 million shares. There was a decline of -2.71%, which implies that there is a negative sentiment for the stock.
